Table 4

Patient characteristics.

Patient Code HLA Class I Typing NY-ESO-1 Status
mRNA Ab
PC1 A*0207,*31;B*46,*56;Cw*01,*04 NDa +
PC2 A*2601;B*4002,*35;Cw*0303,*0304 -b +
PC3 A*0207,*2402;B*46,07*;Cw*01,*07 + +
PC4 A*0201,*2402;B*4001,*52;Cw*0303,*1202 ND -

aND, not determined. bNY-ESO-1 mRNA expression was negative in the primary tumor, but was not determined in metastatic lymph nodes (see text).